Primary aldosteronism (Conn's syndrome)
Endocrine · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
The commonest treatable secondary cause of hypertension, driven by autonomous aldosterone excess. Screen resistant or hypokalaemic hypertension with the aldosterone:renin ratio, distinguish a unilateral adenoma from bilateral hyperplasia, and treat with surgery or an MRA. First action: aldosterone:renin ratio (off interfering drugs where possible).
Red flags
- Refer to endocrinology for confirmation, subtyping (vein sampling) and management, particularly resistant, young-onset or hypokalaemic hypertension
- Admit for severe hypokalaemia or hypertensive emergency
Assessment
Investigations
- Aldosterone:renin ratio as the screening test (raised aldosterone with suppressed renin); withdraw/replace confounding antihypertensives and correct potassium first
- Confirm with a suppression test (e.g. saline infusion)
- Adrenal CT then adrenal vein sampling to lateralise before surgery
- Screen for end-organ damage
Management
- Unilateral disease: laparoscopic adrenalectomy can cure or markedly improve hypertension
- Bilateral disease or non-surgical candidates: mineralocorticoid-receptor antagonist (spironolactone or eplerenone), titrated to BP and potassium
- Monitor renal function and potassium; reinforce lifestyle measures
Disposition
Refer to endocrinology for confirmation, subtyping (vein sampling) and management, particularly resistant, young-onset or hypokalaemic hypertension.
Complications & pitfalls
- Disproportionate cardiovascular and renal damage (stroke, MI, AF, LVH, CKD) from aldosterone excess, and severe hypokalaemia with arrhythmia
Exam pearls
- Screen for primary aldosteronism in anyone with resistant hypertension or hypertension with unexplained (or diuretic-provoked) hypokalaemia — it's far commoner than taught, and a curable cause you'll miss if you don't check the aldosterone:renin ratio.
- Monitoring & follow-up: Post-adrenalectomy BP, potassium and aldosterone to confirm response. On MRA therapy: BP, renal function and potassium, and manage anti-androgen side-effects of spironolactone (switch to eplerenone if troublesome).
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.